Sonoma Pharmaceuticals, Inc. SNOA Q4 2025 earnings

FAQ

When did Sonoma Pharmaceuticals, Inc. report Q4 2025 earnings?

Sonoma Pharmaceuticals, Inc. (SNOA) reported Q4 2025 earnings on February 10, 2026 after market close.

What were Sonoma Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?

Sonoma Pharmaceuticals, Inc. reported revenue of $4.3M and eps of $-0.35 for Q4 2025.

Did Sonoma Pharmaceuticals, Inc. beat estimates in Q4 2025?

Revenue missed the consensus estimate of $5.5M by $1.1M. EPS missed the consensus estimate of $-0.29 by $0.06.

How did Sonoma Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 22.0% from $3.6M a year earlier and eps grew 40.7% from $-0.59.

Where can I find Sonoma Pharmaceuticals, Inc.'s Q4 2025 SEC filings?

You can read the 10-Q periodic report (0001683168-26-000889) directly on SEC EDGAR. The filing index links above go to sec.gov.